HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Water-soluble contrast media in radiography of small bowel obstruction. Comparison of ionic and non-ionic contrast media.

Abstract
Fifty patients with possible gastrointestinal obstruction, referred for enteric follow-through examination, were randomized for a double-blind, parallel comparison of the hyperosmolar contrast medium Gastrografin and the low-osmolar Omnipaque. The result was that Omnipaque retained its radiographic density in the small bowel better than Gastrografin. Omnipaque was thus a better alternative than Gastrografin in follow-through examinations of intestinal obstruction. Also, 23 patients out of 28 with small bowel obstruction due to peritoneal adhesions, had spontaneous relief of symptoms during the observation period following contrast medium ingestion with no significant difference between the two media. This indicated that enteric follow-through procedures may have a therapeutic efficacy similar to the treatment of small bowel obstruction using nasogastric suction and gastrointestinal rest. Possible mechanisms for this action of the contrast media are discussed.
AuthorsA Stordahl, F Laerum, T Gjølberg, I Enge
JournalActa radiologica (Stockholm, Sweden : 1987) (Acta Radiol) 1988 Jan-Feb Vol. 29 Issue 1 Pg. 53-6 ISSN: 0284-1851 [Print] England
PMID2964845 (Publication Type: Clinical Trial, Comparative Study, Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't)
Chemical References
  • Contrast Media
  • Diatrizoate Meglumine
  • Iohexol
Topics
  • Aged
  • Clinical Trials as Topic
  • Contrast Media
  • Diatrizoate Meglumine
  • Double-Blind Method
  • Female
  • Humans
  • Intestinal Obstruction (diagnostic imaging, therapy)
  • Iohexol
  • Male
  • Middle Aged
  • Radiography
  • Random Allocation

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: